Ck Life Sciences Sustainability Profile
Ck Life Sciences, also known as Ck Life Sciences International Holdings, is a prominent biotechnology company headquartered in Hong Kong. Founded in 2000, the company has established itself as a leader in the life sciences sector, focusing on innovative solutions in agricultural biotechnology and healthcare. With a strong presence in Asia and expanding operations globally, Ck Life Sciences is dedicated to developing unique products that enhance crop yields and improve human health. Their core offerings include advanced biopesticides and nutraceuticals, distinguished by their commitment to sustainability and efficacy. Recognised for its pioneering research and development, Ck Life Sciences has achieved significant milestones, positioning itself as a key player in the biotechnology industry. The company continues to drive advancements that contribute to a healthier and more sustainable future.
DitchCarbon Score
How does Ck Life Sciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ck Life Sciences's score of 39 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ck Life Sciences's reported carbon emissions
In 2024, CK Life Sciences reported total carbon emissions of approximately 47,495,000 kg CO2e, comprising about 31,245,000 kg CO2e from Scope 1 and about 16,250,000 kg CO2e from Scope 2 emissions. This represents a slight decrease from 2023, where total emissions were about 48,960,000 kg CO2e, with Scope 1 at approximately 32,037,000 kg CO2e and Scope 2 at about 16,923,000 kg CO2e. The company has set a long-term climate commitment to achieve net-zero emissions by 2050, as outlined in their NGFS Net Zero 2050 target, which commenced in 2019. This commitment encompasses all scopes of emissions, although specific reduction percentages have not been disclosed. CK Life Sciences does not currently report Scope 3 emissions, indicating a focus on direct and indirect emissions from their operations and energy use. The emissions data is not cascaded from a parent company, ensuring that the figures are specific to CK Life Sciences. Overall, CK Life Sciences is actively working towards reducing its carbon footprint while adhering to industry standards for climate accountability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 9,297,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 14,229,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - |
How Carbon Intensive is Ck Life Sciences's Industry?
How Carbon Intensive is Ck Life Sciences's Location?
Ck Life Sciences's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ck Life Sciences has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
